SUMMARY Twenty-four consecutive deaths from a total of 70 children receiving treatment for acute lymphoblastic leukaemia (ALL) have been reviewed. An attempt has been made to ascribe the cause of death to either infection, haemorrhage, the leukaemia itself, or a combination of these factors. No child was free of infection at death. Infection, with or without haemorrhage, was responsible for the deaths of all 15 children whose leukaemia had not relapsed. Although infection was present at death in all 9 children whose leukaemia had relapsed, the leukaemia process itself was also a major contributing factor. Viruses were associated with death in many of the children and may be emerging as important pathogens in children with ALL. Familiarity with a protocol may be an important factor in the prevention of fatal infections in such children. Centralization of treatment is necessary if this expertise is to be acquired.
The use of combination drug therapy and the prophylactic treatment of the central nervous system (CNS) in children with acute lymphoblastic leukaemia (ALL) has resulted in many patients surviving for more than 5 years (Holland and Glidewell, 1972; Simone et al., 1975) . However, prolonged survival has been accompanied by the risk of severe infection in these children who, at times during the course of their treatment, may have impaired immune responses. In order to determine the part played by infection in the death of children with ALL, the last 24 consecutive deaths in such patients treated with combination chemotherapy and CNS prophylaxis in Newcastle upon Tyne have been reviewed. An attempt has been made to ascribe the cause of death to either infection, haemorrhage, the leukaemia itself, or a combination of these factors. Any rational improvement in treatment must be based on an accurate knowledge and explanation of past failures, so in reviewing these deaths we hope to be better able to plan future management. Patients, management, and methods Most of the children with ALL in the Northern Regional Health Authority Area are now referred to one of the two major hospitals in Newcastle upon Tyne for treatment. From a total of 70 children in whom a diagnosis of ALL was made during the (4) or during the first remission (I1) (group I); the remaining 9 children (group II) died after a first or subsequent haematological relapse and all had blast cells in the peripheral blood during their terminal illness. Details of these two groups are given in Tables 1  and 2 . The patients are ranked according to the time interval between diagnosis and death.
Three of the 24 patients were treated with one of the Medical Research Council's UKALL regimens (Medical Research Council Working Party, personal communication, 1976; MacLennan etal., 1976) , while the remaining 21 were treated with a slightly modified version of the best arm of the Acute Leukaemia Group B (ALGB) 6801 protocol (Holland and Glidewell, 1972) . The latter consisted of induction with vincristine and prednisone, weekly intrathecal methotrexate during the 5-week induction phase followed by cranial irradiation with 2400 rads in 12 doses over 19 days, maintenance with continuous 6-mercaptopurine and weekly methotrexate, and intermittent 'pseudo-reinductions' with vincristine, prednisone, and intrathecal methotrexate. The first 7 patients in group I did not survive long enough to receive cranial irradiation.
General supportive care consisted of red cell and platelet transfusions and appropriate antibacterial or antifungal therapy when indicated. Case 7 (Gardner et al., 1967; Gardner and McQuillan, 1974) . Details of 3 of the deaths, Cases 5, 15, and 17, have been reported previously (Sims et al., 1976; Pullan et al., 1976 A total leucocyte count at diagnosis of more than 20 x 109/1 and/or aged 12 or more years was taken as indicating a bad prognosis. Table 3 shows the distribution of cases with good and bad prognosis in the whole group of patients and in the deaths. The results suggest that in the good prognosis group death from infection in remission is a greater hazard than relapse. A necropsy examination was performed in 17 of the 24 children. All of the bacterial infections had been confirmed by ante-mortem blood cultures except in Cases 9 and 10 in group I who both had E. coli urinary tract infections 2 days before death. The virus infections were confirmed either by culturing the virus from post-mortem specimens or by histological appearances. Pneumocystis carinil pneumonitis was diagnosed in life in one child, but in the other 2 only by examination of lung sections. The aspergillus and mucor infections were shown histologically and the Candida albicans by culture from many sites at necropsy examination.
Discussion
This study confirms previous findings that infection is often present at death in children with ALL. Hughes (1971) found that of 199 children with leukaemia, infection was responsible for death in 89 (45%) and only 44 (22%) were completely free of group.bmj.com on June 23, 2017 -Published by http://adc.bmj.com/ Downloaded from infection. Of the 8 deaths in remission reported in the UKALL II trial (MacLennan et al., 1976) , 6 (75%) were associated with infection, while in UKALL I (CNS irradiation) (Medical Research Council, 1975) all 5 deaths in remission were associated with infection. In our series no child was free of infection at death. Infection, with or without haemorrhage, can reasonably be claimed to be the cause of death in the group I patients. In group II, however, the effect of the leukaemic process itself must be taken into account and in these patients it might be reasonable to claim that they all died of 'leukaemia'. The apparent increased frequency of infection in our series may simply reflect more intensive searching for organisms both before and after death.
In Fig. 1 the division of the children into 'predominant' infection groups does not imply certainty of the cause of death. It merely reflects a decision based on a combination of clinical judgement and microbiological and virological evidence in the light of what is already known about the particular organisms. Some children with more than one organism present at death may have been placed in an inappropriate group due to our lack of knowledge of the relative importance of each organism. Except in Case 5, all the bacterial infections were associated with neutropenia. 4 of the 5 deaths in the viral infection group were associated with lymphopenia. The fifth, Case 15, had a prolonged measles encephalitis which in its early stages was associated with a lymphocyte count of 0 6 x 109/1, but which by the time of his death had reached normal levels.
Opportunistic infections with organisms usually of low pathogenicity have frequently been cited as a major cause of infection in immunosuppressed patients (Feigin and Shearer, 1975) . In our series only one of the bacterial infections, that due to Aeromonas hydrophila, is usually considered to be in this category and has previously been reported as causing a fatal infection in leukaemia (Pearson et al., 1972) . However, two of the three fungal infections did involve such organisms. Mucor and aspergillus are both organisms well recognized as pathogens in the compromised host. Although the virus infections cannot be classed as opportunistic, the clinical picture was different from that normally seen in the uncompromised host. Measles, mumps, rhinovirus, and cytomegalovirus (CMV) do not cause such devastating illness in normal subjects. The 2 children who had measles encephalitis have recently been reported (Pullan et al., 1976 Pneumocystis carinii pneumonitis has become common in the South-west United States but until recently it had not been a clinical problem in this country. Many major centres are now seeing an increasing number of patients with this infection which may in part be due to better diagnosis, but it is also possible that more intensive chemotherapy is an important contributing factor. In only one of our patients was the condition diagnosed in life, but this was too late for treatment to be effective. Treatment with cotrimoxazole or pentamidine is successful in many patients in whom an early diagnosis can be made and prophylactic cotrimoxazole may be effective in preventing pneumocystis pneumonitis from occurring (Hughes, 1976) .
Viruses have been found in the lungs or respiratory tract secretions of several of the children at death. Their presence is probably abnormal but their contribution to death is sometimes difficult to determine. A study of all childhood deaths now in progress in Newcastle may clarify the position. However, as many nonleukaemic childhood deaths are associated with respiratory tract illness, it may be some time before a clear picture emerges. Case 19, who died in relapse and whose lungs at necropsy examination contained H-strain rhinovirus, had the histological appearances of interstitial pneumonidis. However, Case 10, who died in remission with a urinary tract infection and parainfluenza virus type 3 and rhinovirus in her lungs, had no typical pneumonitis changes. This difficulty in ascertaining the relative importance of virus infections histologically is due to the poor cellular response and minimal inflammatory exudate in some of these patients. H-strain rhinovirus may be emerging as an important pathogen in children with ALL. CMV pneumonitis, whose clinical appearance may resemble pneumocystis pneumonitis, has been shown to be a cause of death in immunosuppressed patients (Abdallah et al., 1976) .
The interaction of different types of infection is not well understood. Case 12 died of a bacterial infection associated with rhinovirus in nasopharyngeal and tracheobronchial secretions 4 months after a prolonged and severe attack of measles with giant cell pneumonitis. Some virus infections may suppress immune responses and render the host liable to invasion with other organisms. The finding of impaired neutrophil function in normal children with virus infections supports this view (Craft et al., 1976) Similarly, the effects of the interaction of antileukaemic drugs and radiotherapy on the immune mechanism are poorly understood. 4 of the remission deaths, those of Cases 8, 9, 10, and 11, occurred soon after radiotherapy and this phenomenon has beennoted in the UKALL trials (MacLennan et al., 1976) .
A marked fall in the lymphocyte count with a relatively greater depression of B lymphocytes after radiotherapy (Esber et al., 1976; Reid et al., 1977) may, in part, account for this increased susceptibility to infection.
It is worth emphasizing that almost two-thirds of the deaths in our series were due to infection in patients whose leukaemia had not relapsed. The deaths during remission induction (5*7%) are rather high but if the baby (Case 4) is excluded this is reduced to 4 * 3 % which is comparable to the 3 % in the study of Hughes and Smith (1973) but slightly higher than in the UKALL I study where it was 2 % (Johnston et al., 1974) . Fortunately, the number of patients who did suffer a relapse is small and the overall survival continues to be encouraging. Within any treatment regimen there needs to be a balance between obtaining the best control of the disease and incurring severe infection. Prevention of these deaths during remission and induction would significantly improve survival figures.
Two approaches are available to combat the problem of infection in these patients. One can try to both prevent infection and improve the methods of treatment of established infections. 6-month periods in which the deaths in our series occurred. The decreasing number of patients in remission dying of infection in the later part of the study and the absence of any deaths in remission for over 1 year despite a steadily increasing population ofchildren being treated for ALL suggests that familiarity with a protocol may be an important factor in the prevention of fatal infections. Protective isolation and gut sterilization are possible in certain centres but the amount of increased nursing work that these entail may be formidable. It is difficult to assess the contribution of protective isolation to the falling number of remission deaths in our series. Children who have been in contact with measles and chicken pox may be partially protected by pooled or specific gammaglobulin.
Treatment of bacterial, fungal, and pneumocystis infection is possible with antibiotics and other chemotherapeutic agents, and when these fail to control the infection in neutropenic patients, white cell transfusions are now of proven benefit (Graw and Appelbaum, 1977) . It is possible that we averted one remission death in 1976 by white cell transfusions.
Viral infections may be emerging as an important contribution to the mortality of children with ALL. Rapid ante-mortem diagnosis of viral infections will enable clinicians to take full advantage of effective antiviral agents as they become available.
However, within the framework of existing antileukaemic therapy schedules, the most important factor in prevention of death from infection is the acquisition of clinical expertise in treating children with ALL. This can only be achieved by the centralization of treatment and by the co-operation and sharing of knowledge between treatment centres.
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